Morfouace, M.
Novello, S.
Stevovic, A.
Dooms, C.
Janžič, U.
Berghmans, T.
Dziadziuszko, R.
Gorlia, T.
Felip, E.
Paz-Ares, L.
Mazieres, J.
O’Brien, M.
Bironzo, P.
Vansteenkiste, J.
Lacroix, L.
Dingemans, A. C.
Golfinopoulos, V.
Besse, B.
Article History
Received: 8 February 2022
Accepted: 18 April 2022
First Online: 18 May 2022
Competing interests
: Dr. Morfouace, A. Stevovic, Dr. Gorlia, Dr. Golfinopoulos, Dr. Dooms, Dr. Janžič, Dr. Berghmans, Dr. O’Brien, Dr. Bironzo, Dr. Vansteenkiste and Dr. Lacroix declare no competing interests. Dr. MAZIERES reports: Personal fees from Roche, Astra Zeneca, Pierre Fabre, Takeda, BMS, MSD, Jiangsu Hengrui, Blueprint, Daiichi, Novartis, Amgen. Grants from Roche, Astra Zeneca, Pierre Fabre, BMS. Dr. DINGEMANS reports: Attending advisory boards and/or provided lectures for: Roche, Eli Lilly, Boehringer Ingelheim, Astra Zeneca, Pfizer, BMS, Amgen, Novartis, MSD, Takeda, Pharmamar. Receiving research support from BMS, AbbVie, Amgen (all paid to her institute). Dr. NOVELLO reports: Being an advisor/Speaker bureau: AZ, AMG, BI, Beigene, MSD, Eli Lilly, Roche, Takeda, Pfizer, Roche, Sanofi, Novartis. Dr. FELIP reports: Advisory Role or Speaker’s Bureau: Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, F. Hoffmann-La Roche, Glaxo Smith Kline, Janssen, Medscape, Merck KGaA, Merck Sharp & Dohme, Novartis, Peptomyc, PeerVoice, Pfizer, Regeneron, Sanofi Genzyme, Syneos Health, Seattle Genetics, Takeda, Touch Medical. Board member: Grifols, Independent member. Research Funding: Fundación Merck Salud, Grant for Oncology Innovation, Merck Healthcare KGaA. Dr. PAZ-ARES reports: Grants or contracts from any entity: MSD, Astrazeneca, Pfizer, BMS. Consulting fees: Lilly, MSD, Roche, Pharmamar, Merck, Astrazeneca, Novartis, Servier, Amgen, Pfizer, Ipsen, Sanofi, Bayer, Blueprint, BMS, Mirati. Payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing or educational events: Astrazeneca, Janssen, Merck, Mirati, Sanofi. Leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid: Genomica, Altum sequency. Dr. DZIADZUSZKO reports: Advisory role/compensated: AstraZeneca, Roche, Novartis, MSD, Pfizer, Boehringer Ingelheim, FoundationMedicine, Karyopharm, Takeda. Dr. BESSE reports: Sponsored Research at Gustave Roussy Cancer Center: 4D Pharma, Abbvie, Amgen, Aptitude Health, AstraZeneca, BeiGene, Blueprint Medicines, BMS, Boehringer Ingelheim, Celgene, Cergentis, Cristal Therapeutics, Daiichi-Sankyo, Eli Lilly, GSK, Inivata, Janssen, Onxeo, OSE immunotherapeutics, Pfizer, Roche-Genentech, Sanofi, Takeda, Tolero Pharmaceuticals.